Meet Our Leading Team

Genomic testing cooperative team

Chief Executive Officer
Chief Medical Officer

Chief Operations Officer

Vice President,
Business Development

Director,
Research & Development

Director,
Biostatistics & AI​

Chief Commercial Officer
Chief Information Officer

GTC favicon

Megan Martin

Vice President
Facilities Management & HR

GTC favicon

Board of Directors

Chairman
of the Board

Board Member

Board Member

Board Member

Maher Albitar, M.D. - Chief Executive Officer, Chief Medical Officer

GTC - Maher Albitar, M.D.Dr. Albitar has extensive experience in anatomic/clinical pathology, hematopathology, and molecular pathology. He also has extensive business and administrative experience as an executive leader of large laboratories, Board member, and director of large scientific and genomic diagnostic studies. Until recently, Dr. Albitar was the Senior Vice President, Chief Medical Officer and Director of Research and Development at NeoGenomics.

He is credit of transforming the NeoGenomics Laboratories from FISH testing company to a company offering the most sophisticated molecular testing. Prior to NeoGenomics, Dr. Albitar served as the Medical Director for Hematopathology and Oncology, Nichols Institute, Quest Diagnostics, and Chief R&D for Hematopathology and Oncology for Quest Diagnostics from 2003 to 2010. From 1991 to 2003, Dr. Albitar held various faculty positions at the University of Texas MD Anderson Cancer Center, including Section Chief of Leukemia Section in Laboratory Medicine and Pathology Department, Director of the molecular laboratory and Director of Hematopathology Fellowship program.

Dr. Albitar was a tenured full professor in Pathology and Leukemia at the time of leaving MD Anderson Cancer Center. Dr. Albitar is certified AP/CP pathologist with fellowship training in Hematopathology and molecular pathology. After his training in Hematopathology, Dr. Albitar spent 4 years in Physician/Scientist training program at the University of Pennsylvania/Howard Hughes Medical Institute and the Department of Genetics. Dr. Albitar has published more than 300 peer-reviewed papers, book chapters, and review articles. He is the lead inventor on more than 50 different patents and patent applications.

Dr. Maher Albitar is the founder and CEO of Genomic Testing Cooperative, LCA.

GTC - Maher Albitar, M.D.Dr. Albitar has extensive experience in anatomic/clinical pathology, hematopathology, and molecular pathology. He also has extensive business and administrative experience as an executive leader of large laboratories, Board member, and director of large scientific and genomic diagnostic studies. Until recently, Dr. Albitar was the Senior Vice President, Chief Medical Officer and Director of Research and Development at NeoGenomics.

He is credit of transforming the NeoGenomics Laboratories from FISH testing company to a company offering the most sophisticated molecular testing. Prior to NeoGenomics, Dr. Albitar served as the Medical Director for Hematopathology and Oncology, Nichols Institute, Quest Diagnostics, and Chief R&D for Hematopathology and Oncology for Quest Diagnostics from 2003 to 2010. From 1991 to 2003, Dr. Albitar held various faculty positions at the University of Texas MD Anderson Cancer Center, including Section Chief of Leukemia Section in Laboratory Medicine and Pathology Department, Director of the molecular laboratory and Director of Hematopathology Fellowship program.

Dr. Albitar was a tenured full professor in Pathology and Leukemia at the time of leaving MD Anderson Cancer Center. Dr. Albitar is certified AP/CP pathologist with fellowship training in Hematopathology and molecular pathology. After his training in Hematopathology, Dr. Albitar spent 4 years in Physician/Scientist training program at the University of Pennsylvania/Howard Hughes Medical Institute and the Department of Genetics. Dr. Albitar has published more than 300 peer-reviewed papers, book chapters, and review articles. He is the lead inventor on more than 50 different patents and patent applications.

Dr. Maher Albitar is the founder and CEO of Genomic Testing Cooperative, LCA.

Lawrence M. Eck, CLS, MT (ASCP) - Chief Operations Officer

GTC-Eck Lawrence - CLS, MT (ASCP)Lawrence has over 30 years of experience in clinical laboratory operations, testing, accreditation and management. From 2012 until 2018, Lawrence was at NeoGenomics Director of the California Operations and Director of Molecular Operations. From 2003 to 2012 he was at Nichols Institute, Quest Diagnostic as a manager of Biochemical Genetics and the Hematology/Oncology Laboratory. 

Prior to that, he worked in leadership positions at multiple clinical laboratories including Group Health Cooperative, US Laboratories and SmithKline Beecham Laboratories. Lawrence has a bachelor of science degree in biology from California State University, Northridge. 

GTC-Eck Lawrence - CLS, MT (ASCP)Lawrence has over 30 years of experience in clinical laboratory operations, testing, accreditation and management. From 2012 until 2018, Lawrence was at NeoGenomics Director of the California Operations and Director of Molecular Operations. From 2003 to 2012 he was at Nichols Institute, Quest Diagnostic as a manager of Biochemical Genetics and the Hematology/Oncology Laboratory. 

Prior to that, he worked in leadership positions at multiple clinical laboratories including Group Health Cooperative, US Laboratories and SmithKline Beecham Laboratories. Lawrence has a bachelor of science degree in biology from California State University, Northridge. 

Jennifer Varca - Vice President, Business Development​

GTC-Varca, Jennifer (GTC's Vice President)Jennifer Varca is responsible for the company’s business development activities, strategy, recruiting Co-Op members, and joint ventures. Jennifer brings years of commercial leadership experience in the diagnostics and home healthcare industries to GTC. She previously led sales within the Health Systems Division for Quest Diagnostics Nichols Institute with a focus on advanced diagnostics. While there, she served as a vital influencer of the region’s strategic growth and development.

Prior to her experience with Quest, she spent more than 10 years as a Senior Executive for Maxim Healthcare Services where she was responsible for business development and the continuum of care for skilled nursing and home health services.

Jennifer earned her Bachelor of Arts degree in Communications from California Polytechnic, San Luis Obispo, where she was a four-year member of the Women’s Division I Soccer team.

GTC-Varca, Jennifer (GTC's Vice President)Jennifer Varca is responsible for the company’s business development activities, strategy, recruiting Co-Op members, and joint ventures. Jennifer brings years of commercial leadership experience in the diagnostics and home healthcare industries to GTC. She previously led sales within the Health Systems Division for Quest Diagnostics Nichols Institute with a focus on advanced diagnostics. While there, she served as a vital influencer of the region’s strategic growth and development.

Prior to her experience with Quest, she spent more than 10 years as a Senior Executive for Maxim Healthcare Services where she was responsible for business development and the continuum of care for skilled nursing and home health services.

Jennifer earned her Bachelor of Arts degree in Communications from California Polytechnic, San Luis Obispo, where she was a four-year member of the Women’s Division I Soccer team.

Wanlong Ma - Director, Research & Development

GTC-Wanlong MaWanlong Ma has extensive experience in molecular testing, next-generation sequencing and developing clinical tests. She obtained her MS degree from the University of Southern California in 1991. She also has a master’s degree in Pharmaceutical Science from the University of Shen-Yang, P.R. China. She is CA certified Clinical Genetic Molecular Biology Scientist and ASCP certified. She was responsible for test development at NeoGenomics from 2012 to 2018.

Prior to that from 1994 to 2011 she was at the Nichols Institute, Quest Diagnostics as a lead/Sr R&D Scientist and R&D manager. She developed and validated most of the molecular tests for the Hematology/Oncology Department. Ms. Ma co-authored more than 40 papers and was the first author in several papers.

GTC-Wanlong MaWanlong Ma has extensive experience in molecular testing, next-generation sequencing and developing clinical tests. She obtained her MS degree from the University of Southern California in 1991. She also has a master’s degree in Pharmaceutical Science from the University of Shen-Yang, P.R. China. She is CA certified Clinical Genetic Molecular Biology Scientist and ASCP certified. She was responsible for test development at NeoGenomics from 2012 to 2018.

Prior to that from 1994 to 2011 she was at the Nichols Institute, Quest Diagnostics as a lead/Sr R&D Scientist and R&D manager. She developed and validated most of the molecular tests for the Hematology/Oncology Department. Ms. Ma co-authored more than 40 papers and was the first author in several papers.

Babak Shahbaba, PhD - Director, Biostatistics & AI​

Babak Shahbaba, PhDBabak Shahbaba is a Professor of Statistics. His independent research focuses on Bayesian methods and their applications in large-scale biological sciences. His research experience spans a broad spectrum of novel and high-impact areas that includes statistical methodologies (Bayesian nonparametrics and hierarchical Bayesian models), computational methods (efficient sampling algorithms), and a wide range of applied and collaborative projects.

Babak Shahbaba, PhDBabak Shahbaba is a Professor of Statistics. His independent research focuses on Bayesian methods and their applications in large-scale biological sciences. His research experience spans a broad spectrum of novel and high-impact areas that includes statistical methodologies (Bayesian nonparametrics and hierarchical Bayesian models), computational methods (efficient sampling algorithms), and a wide range of applied and collaborative projects.

Arie Shen - Chief Commercial Officer, Chief Information Officer

Arie Shen / Genomic Testing Cooperative CCO & CIOSoftware creation and implementation, Executive Sales and Business Development, Branding and Marketing, Technology Project Management, Entrepreneur and Investor.

For more than two decades, Shen managed and lead software projects, software creation and Implementations, and ran P&L operations with sales responsibility for publicly traded software vendors. Subsequently, Shen has enjoyed a diverse and successful consulting career growing companies and leveraging business opportunities. With his broad international background, experience and training, he has successfully guided a wide range of companies, including B2B, B2C and non-profit organizations. In addition to technology project management, Shen is expert in creating and implementing management strategy: developing and executing market penetration, defining strategies for growth and allocating resources to achieve them, and selecting and negotiating joint venture opportunities.

Arie Shen / Genomic Testing Cooperative CCO & CIOSoftware creation and implementation, Executive Sales and Business Development, Branding and Marketing, Technology Project Management, Entrepreneur and Investor.

For more than two decades, Shen managed and lead software projects, software creation and Implementations, and ran P&L operations with sales responsibility for publicly traded software vendors. Subsequently, Shen has enjoyed a diverse and successful consulting career growing companies and leveraging business opportunities. With his broad international background, experience and training, he has successfully guided a wide range of companies, including B2B, B2C and non-profit organizations. In addition to technology project management, Shen is expert in creating and implementing management strategy: developing and executing market penetration, defining strategies for growth and allocating resources to achieve them, and selecting and negotiating joint venture opportunities.